معرفی
Kevin Haworth, PhD, is an Associate Professor in the Department of Internal Medicine at the University of Cincinnati, leading the Biomedical Ultrasonics and Cavitation Laboratory (BUCL). His research focuses on ultrasound and cavitation for therapeutic applications, particularly acoustic droplet vaporization (ADV) and passive cavitation imaging. BUCL is part of the Image-guided Ultrasound Therapeutics Laboratories and collaborates with institutions like Cincinnati Children's Hospital and the University of Chicago. Dr. Haworth has developed novel methods to inhibit reperfusion injury through oxygen scavenging and advanced ultrasound-mediated drug delivery systems.
Education: B.S. in Physics (Truman State University), M.S./Ph.D. in Applied Physics (University of Michigan). Awards include the Acoustical Society of America Fellowship, UC Sigma Xi Young Investigator Award, and NIH K25 Grant. His work has been highlighted in high-impact journals and conferences, including the Fields Institute workshop on High-Intensity Focused Ultrasound.
Key research areas include therapeutic ultrasound applications, cavitation monitoring, and translational medicine. Recent projects involve improving thrombolysis efficacy via histotripsy and ADV-based oxygen scavenging in myocardial reperfusion injury. Collaborators include Christy Holland, Andrew Redington, and Kenneth Bader. BUCL trains students and postdocs in biomedical engineering, physics, and clinical research.
Publications span over 50 peer-reviewed articles, with a focus on ultrasound therapy, cavitation physics, and cardiovascular health. Notable grants include NIH funding for ADV in stroke therapy and oxygen scavenging. The lab actively participates in industry partnerships (e.g., EKOS Corp) and clinical trials for ultrasound-enhanced treatments.
